139 related articles for article (PubMed ID: 35421932)
21. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases.
Han L; Guo X; Du R; Guo K; Qi P; Bian H
J Ovarian Res; 2022 Jun; 15(1):75. PubMed ID: 35739532
[TBL] [Abstract][Full Text] [Related]
22. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
23. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
[TBL] [Abstract][Full Text] [Related]
24. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
25. Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer.
Wang W; Zhang W; Hu Y
PeerJ; 2021; 9():e12353. PubMed ID: 34820170
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.
Winder DM; Chattopadhyay A; Muralidhar B; Bauer J; English WR; Zhang X; Karagavriilidou K; Roberts I; Pett MR; Murphy G; Coleman N
J Pathol; 2011 Nov; 225(3):448-62. PubMed ID: 21952923
[TBL] [Abstract][Full Text] [Related]
27. N
Lin X; Wang F; Chen J; Liu J; Lin YB; Li L; Chen CB; Xu Q
Mil Med Res; 2022 Apr; 9(1):19. PubMed ID: 35418160
[TBL] [Abstract][Full Text] [Related]
28. Hiwi facilitates chemoresistance as a cancer stem cell marker in cervical cancer.
Liu W; Gao Q; Chen K; Xue X; Li M; Chen Q; Zhu G; Gao Y
Oncol Rep; 2014 Nov; 32(5):1853-60. PubMed ID: 25119492
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study of genes related to concomitant chemoradiotherapy resistance in advanced uterine cervical squamous cell carcinoma.
An JS; Huang MN; Song YM; Li N; Wu LY; Zhan QM
Chin Med J (Engl); 2013 Nov; 126(21):4109-15. PubMed ID: 24229683
[TBL] [Abstract][Full Text] [Related]
30. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
31. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
[TBL] [Abstract][Full Text] [Related]
32. [Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Takeda S; Ikeba K; Ohokubo T; Sodemoto T; Yamamoto T; Takagi A; Hayashi N; Kinoshita K
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1697-703. PubMed ID: 8886048
[TBL] [Abstract][Full Text] [Related]
33. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
Mellish KJ; Kelland LR; Harrap KR
Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.
Peng G; Dan W; Jun W; Junjun Y; Tong R; Baoli Z; Yang X
Tumour Biol; 2015 May; 36(5):3309-17. PubMed ID: 25586346
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
[TBL] [Abstract][Full Text] [Related]
36. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
Jiang D; Ren C; Yang L; Li F; Yang X; Zheng Y; Ji X; Tian Y
J Obstet Gynaecol Res; 2021 Jul; 47(7):2433-2441. PubMed ID: 34028125
[TBL] [Abstract][Full Text] [Related]
37. Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
Rubinsak LA; Cohen C; Khanna N; Horowitz IR; Hanley KZ
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):567-572. PubMed ID: 27941566
[TBL] [Abstract][Full Text] [Related]
38. Quantitative proteomic analysis of cervical cancer based on TMT-labeled quantitative proteomics.
Xu D; Zhu X; Ren J; Huang S; Xiao Z; Jiang H; Tan Y
J Proteomics; 2022 Feb; 252():104453. PubMed ID: 34915198
[TBL] [Abstract][Full Text] [Related]
39. Use of mesothelin as a tumor-associated antigen in cervical squamous cell carcinoma.
He Y; Zhao H; Li XM; Yin CH; Wu YM
Gene; 2019 Mar; 690():30-37. PubMed ID: 30583024
[TBL] [Abstract][Full Text] [Related]
40. miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer.
Shen Y; Wang P; Li Y; Ye F; Wang F; Wan X; Cheng X; Lu W; Xie X
Br J Cancer; 2013 Jul; 109(1):92-9. PubMed ID: 23778521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
